Santhera Pharmaceuticals Holding AG (SPHDF)
19.79
0.00 (0.00%)
USD |
OTCM |
Sep 18, 16:00
Santhera Pharmaceuticals Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Basilea Pharmaceutica AG | -- |
| BeOne Medicines Ltd. | -49.41M |
| AC Immune SA | -- |
| CRISPR Therapeutics AG | -55.66M |
| Idorsia Ltd. | -3.521M |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow | -43.53M |
| Free Cash Flow Yield | -16.81% |